Parallax Volatility Advisers’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.2M | Buy |
156,666
+44,653
| +40% | +$3.99M | 0.03% | 301 |
|
|
2026
Q1 | $8.67M | Buy |
112,013
+105,704
| +1,675% | +$8.14M | 0.02% | 446 |
|
|
2025
Q4 | $501K | Sell |
6,309
-205,223
| -97% | -$16.2M | ﹤0.01% | 1228 |
|
|
2025
Q3 | $15.9M | Buy |
211,532
+39,174
| +23% | +$2.68M | 0.02% | 335 |
|
|
2025
Q2 | $11.9M | Buy |
172,358
+113,795
| +194% | +$7.46M | 0.03% | 379 |
|
|
2025
Q1 | $3.97M | Sell |
58,563
-324,748
| -85% | -$19.4M | 0.01% | 682 |
|
|
2024
Q4 | $17.2M | Buy |
383,311
+342,254
| +834% | +$19.2M | 0.03% | 383 |
|
|
2024
Q3 | $2.58M | Buy |
41,057
+13,550
| +49% | +$791K | ﹤0.01% | 1050 |
|
|
2024
Q2 | $1.62M | Buy |
+27,507
| New | +$1.72M | ﹤0.01% | 1108 |
|
|
2023
Q3 | – | Sell |
-480
| Closed | -$34K | – | 2338 |
|
|
2023
Q2 | $33.2K | Sell |
480
-68,765
| -99% | -$4.89M | ﹤0.01% | 2106 |
|
|
2023
Q1 | $5.15M | Buy |
69,245
+11,093
| +19% | +$930K | 0.01% | 846 |
|
|
2022
Q4 | $5.42M | Buy |
+58,152
| New | +$5.61M | 0.01% | 994 |
|
|
2020
Q4 | – | Sell |
-481,234
| Closed | -$28.1M | – | 2714 |
|
|
2020
Q3 | $28.1M | Buy |
481,234
+64,093
| +15% | +$3.99M | 0.02% | 603 |
|
|
2020
Q2 | $27.1M | Sell |
417,141
-319,485
| -43% | -$20.1M | 0.03% | 424 |
|
|
2020
Q1 | $43.7M | Buy |
736,626
+459,255
| +166% | +$30.7M | 0.06% | 225 |
|
|
2019
Q4 | $20.6M | Sell |
277,371
-311,203
| -53% | -$21.9M | 0.02% | 420 |
|
|
2019
Q3 | $37.1M | Sell |
588,574
-113,190
| -16% | -$6.71M | 0.04% | 234 |
|
|
2019
Q2 | $38.2M | Buy |
701,764
+56,919
| +9% | +$3.07M | 0.04% | 219 |
|
|
2019
Q1 | $34.8M | Buy |
644,845
+593,691
| +1,161% | +$36.6M | 0.04% | 220 |
|
|
2018
Q4 | $3.35M | Buy |
+51,154
| New | +$3.82M | ﹤0.01% | 852 |
|
|
2018
Q3 | – | Sell |
-75,541
| Closed | -$5.4M | – | 2675 |
|
|
2018
Q2 | $4.86M | Buy |
75,541
+13,370
| +22% | +$881K | 0.01% | 629 |
|
|
2018
Q1 | $3.87M | Sell |
62,171
-94,854
| -60% | -$6.81M | 0.01% | 591 |
|
|
2017
Q4 | $11.4M | Buy |
+157,025
| New | +$11.4M | 0.02% | 374 |
|
|
2016
Q4 | – | Sell |
-52,542
| Closed | -$4.25M | – | 3155 |
|
|
2016
Q3 | $4.68M | Buy |
+52,542
| New | +$4.96M | 0.01% | 696 |
|
|
2016
Q1 | – | Sell |
-10,302
| Closed | -$1M | – | 2630 |
|
|
2015
Q4 | $1.01M | Sell |
10,302
-194,685
| -95% | -$19.1M | ﹤0.01% | 1276 |
|
|
2015
Q3 | $19.8M | Buy |
204,987
+204,726
| +78,439% | +$21.5M | 0.04% | 270 |
|
|
2015
Q2 | $27K | Sell |
261
-1,952
| -88% | -$199K | ﹤0.01% | 2797 |
|
|
2015
Q1 | $228K | Sell |
2,213
-21,214
| -91% | -$2.15M | ﹤0.01% | 2007 |
|
|
2014
Q4 | $2.26M | Buy |
23,427
+2,898
| +14% | +$255K | 0.01% | 1020 |
|
|
2014
Q3 | $1.63M | Buy |
20,529
+12,266
| +148% | +$967K | 0.01% | 1208 |
|
|
2014
Q2 | $623K | Buy |
8,263
+4,741
| +135% | +$358K | ﹤0.01% | 1277 |
|
|
2014
Q1 | $264K | Buy |
3,522
+2,452
| +229% | +$173K | ﹤0.01% | 1314 |
|
|
2013
Q4 | $77K | Buy |
+1,070
| New | +$68.7K | ﹤0.01% | 1992 |
|
|
2013
Q3 | – | Sell |
-30,304
| Closed | -$1.81M | – | 3065 |
|
|
2013
Q2 | $1.73M | Buy |
+30,304
| New | +$1.76M | 0.01% | 615 |
|
Other funds holding CVS
Parallax Volatility Advisers's CVS Position: Q2 2026 in Review
Parallax Volatility Advisers increased its CVS Health (CVS) stake by 40% in Q2 2026, buying an estimated $3.99M and bringing the position to 156,666 shares worth $16.2M. The position accounts for 0.03% of the portfolio, ranked #301.
Parallax Volatility Advisers first reported a position in CVS in Q2 2013 and has held it in 34 quarters since. The position peaked at $43.7M in Q1 2020. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Parallax Volatility Advisers held 156,666 shares of CVS Health worth $16.2M as of Q2 2026.
- Parallax Volatility Advisers bought 44,653 CVS Health shares in Q2 2026, an estimated $3.99M.
- CVS Health made up 0.03% of Parallax Volatility Advisers's portfolio in Q2 2026, its #301 holding.
- Parallax Volatility Advisers first reported a position in CVS Health in Q2 2013 and has held it in 34 quarters since.
- Parallax Volatility Advisers's CVS Health position peaked at $43.7M in Q1 2020.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Parallax Volatility Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.